Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 7

Klasik aterosklerotik risk faktörü bulunmayan plak tipi psoriasisi olan hastalarda subklinik aterosklerozun değerlendirilmesi

Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis

Pages
574–580
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: PWV, and the maximum and average CIMT values of psoriasis patients were higher than those of the healthy group (PWV: 7.04±1.1 m/sn vs. 6.03±0.61 m/sn, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Systemic inflammation plays an important role in the pathogenesis of atherosclerosis in psoriasis patients.
📊
Key Findings & Data:Study design: Fifty-seven plaque-type psoriasis patients (31 males, 26 females; mean age 41±10.8 years) and 60 healthy individuals (32 males, 28 females; mean age 40±9.4 years) were included.
💡
Conclusion & Impact:Results: PWV, and the maximum and average CIMT values of psoriasis patients were higher than those of the healthy group (PWV: 7.04±1.1 m/sn vs. 6.03±0.61 m/sn, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Systemic inflammation plays an important role in the pathogenesis of atherosclerosis in psoriasis patients. Therefore, persistent skin inflammation in psoriasis patients may contribute to the development of premature atherosclerosis, as it occurs in rheumatoid arthritis and systemic lupus erythematosus. We aimed to evaluate the relationship between subclinical atherosclerosis and psoriasis by using pulse wave velocity (PWV) and the measurement of carotid intima media thickness (CIMT) in psoriatic patients. Study design: Fifty-seven plaque-type psoriasis patients (31 males, 26 females; mean age 41±10.8 years) and 60 healthy individuals (32 males, 28 females; mean age 40±9.4 years) were included. Atherosclerotic risk factors were excluded in both of the groups. Demographic, bio-chemical data, psoriasis area and severity index (PASI) score of the psoriasis group, and disease duration were recorded. Carotid- femoral artery PWV and CIMT values were compared. Results: PWV, and the maximum and average CIMT values of psoriasis patients were higher than those of the healthy group (PWV: 7.04±1.1 m/sn vs. 6.03±0.61 m/sn, p

Özet

Amaç: Psoriasisli hastalarda görülen sistemik enflamasyon ateroskleroz gelişiminde önemli rol oynayabilir. Bu hastalarda görülen kronik enflamasyon, romatoid artrit ve sistemik lupus eritamozuslu hastalarda olduğu gibi erken ateroskleroz gelişimine katkıda bulunabilir. Çalışmamızda, nabız dalga hızı (NDH) ve karotis intima medya kalınlığı (KİMK) ölçüm yöntemleri kullanarak, psoriasis ile subklinik ateroskleroz arasındaki ilişkinin araştırılması amaçlandı. Çalışma planı: Klasik ateroskleroz risk faktörleri bulunmayan, plak tipi psoriasisi olan 57 hasta (31 erkek, 26 kadın; ort. yaş 41±10.8 yıl) ve 60 sağlıklı birey (32 erkek, 28 kadın; ort. yaş. 40±9.4 yıl) çalışmaya alındı. Çalışmaya alınan bireylerin demografik, biyokimyasal verilerine ek olarak, hastalıklı bireylerde psoriasis alanını ve ciddiyet indeksini ölçen PASİ skoru ve hastalığın süresi kayıt edildi. Sağlıklı ve psoriasisli olgularda karotis ve femoral arterlerde yapılan NDH ve KİMK ölçümleri karşılaştırıldı. Bulgular: NDH, maksimal ve ortalama KİMK değerleri psoriasis grubunda, sağlıklı gruptan fazla bulundu (sırasıyla, NDH: 7.04±1.1 m/sn ve 6.03±0.61 m/sn, p

🔖

Cite This Article

BAŞARICI, İ., DEMİR, İ., KOÇ, S., ALTEKİN, E. R., ALPSOY, E., KARAKAŞ, M. S., YANIKOĞLU, A. (2022). Klasik aterosklerotik risk faktörü bulunmayan plak tipi psoriasisi olan hastalarda subklinik aterosklerozun değerlendirilmesi. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 7, 574–580. https://ajindex.com/articles/632983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Zhu TY, Li EK, Tam LS. Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol 2012;2012:714321. Epub 2012 May 8
  2. Atzeni F, Turiel M, Boccassini L, Sitia S, Tomasoni L, Battellino M, et al. Cardiovascular involvement in psoriatic arthritis. Reumatismo 2011;63:148-54
  3. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007;56:629-34
  4. Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009;35:313-24
  5. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402- 11
  6. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406
  7. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841-50
  8. Wright CI, Brouwer-de Cock KA, Kroner CI, Hoeks AP, Draijer R. The relation of arterial stiffness to endothelial function in healthy subjects. Physiol Meas 2007;28:573-82
  9. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep 2007;9:139- 44
  10. Mukherjee D, Yadav JS. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 2002;144:753-9
  11. Tam LS, Shang Q, Li EK, Tomlinson B, Chu TT, Li M, et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008;59:1322-31
  12. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009;161:1-7
  13. Späh F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008;159:10-7. 14. del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arth